Associate Professor of Pathology, Assistant Professor of Oncology, Johns Hopkins University School of Medicine
Pathology
Dr. Robert A. Anders, MD
|
|
Give Review
Robert A. Anders practices Pathology. He attended Mayo Medical School. Mayo Medical School is ranked 27/42 in Research/PrimaryCare. Doctor Robert A. Anders, MD is a published doctor. He has 95 papers published. The most current publication "Differential requirement for type I and type II transforming growth factor beta receptor kinase activity in ligand-mediated receptor endocytosis." Dr. Robert A. Anders is registered with Medicare.
Publications
- Using Quantitative Seroproteomics to Identify Antibody Biomarkers in Pancreatic Cancer.
- PD-L1 Expression as a Predictive Biomarker: Is Absence of Proof the Same as Proof of Absence?
- A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hep...
- LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma.
- PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation.
- Pharmacological activation of myosin II paralogs to correct cell mechanics defects.
- The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.
- Benign Solid Tumors of the Liver: Management in the Modern Era.
- Integrin β-8, But Not β-5 or -6, Protein Expression Is Increased in Livers of Children With Biliary Atresia.
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors.
- The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy.
- Genomic Profiling of Intrahepatic Cholangiocarcinoma: Refining Prognosis and Identifying Therapeutic Targets.
- Segmental Atrophy of the Liver: An Uncommon and Often Unrecognized Pseudotumor.
- Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years.
- The use of Yes-associated protein expression in the diagnosis of persistent neonatal cholestatic liver disease.
- Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection.
- The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome.
- Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.
- Patterns of Consultation and Treatment of Patients with Hepatocellular Carcinoma Presenting to a Large Academic Medical Center in the US.
- Erratum to: Prevalence of Nonalcoholic Steatohepatitis Among Patients with Resectable Intrahepatic Cholangiocarcinoma.
- PD-L1 expression in the Merkel cell carcinoma microenvironment: Association with inflammation, Merkel cell polyomavirus and overall survival.
- Impact of a single-day multidisciplinary clinic on the management of patients with liver tumours.
- Prevalence of Nonalcoholic Steatohepatitis Among Patients with Resectable Intrahepatic Cholangiocarcinoma.
- Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody.
- HIF-2α inhibits hepatocellular carcinoma growth through the TFDP3/E2F1-dependent apoptotic pathway.
- Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients.
- Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies.
- Sarcina organisms in the gastrointestinal tract: a clinicopathologic and molecular study.
- Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver.
- A Polymeric Nanoparticle Encapsulated Hedgehog Pathway Inhibitor HPI-1 (NanoHHI) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma.
- Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.
- Shifting trends in liver-directed management of patients with colorectal liver metastasis: A population-based analysis.
- A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and s...
- Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth.
- Hilar cholangiocarcinoma: tumor depth as a predictor of outcome.
- The Role of Liver-directed Surgery in Patients with Hepatic Metastasis from a Gynecologic Primary Carcinoma.
- Hyperplastic luschka ducts: a mimic of adenocarcinoma in the gallbladder fossa.
- Hedgehog activity, epithelial-mesenchymal transitions, and biliary dysmorphogenesis in biliary atresia.
- Variation in lymph node assessment after colon cancer resection: patient, surgeon, pathologist, or hospital?
- Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.
- Hepatocellular carcinoma in a teenager with perinatally acquired HIV Infection without hepatitis B or C coinfection: a case report.
- Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.
- The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.
- Autoimmune hepatitis in patients with primary Sjögren's syndrome: a series of two-hundred and two patients.
- Tc17 CD8 T cells: functional plasticity and subset diversity.
- Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma.
- Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab.
- Hepatitis in common variable immunodeficiency.
- The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
- T cell-derived lymphotoxin regulates liver regeneration.
- Immunostaining of plasma cells in primary biliary cirrhosis.
- KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.
- Metastatic renal cell carcinoma within a hepatic focal nodular hyperplasia: a case report and review of the literature.
- Expression of Yes-associated protein in common solid tumors.
- Gadd45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling.
- Elucidation of a universal size-control mechanism in Drosophila and mammals.
- Hepatotoxicity associated with dietary supplements containing anabolic steroids.
- Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease.
- Biopsy considerations in the diagnosis of hepatic masses.
- Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility.
- Glycogen pseudoground glass change in hepatocytes.
- Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma.
- The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway.
- Contribution of the lymphotoxin beta receptor to liver regeneration.
- The critical role of LIGHT in promoting intestinal inflammation and Crohn's disease.
- The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses.
- Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection.
- Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy.
- Caveolin and thrombospondin expression during hepatocellular carcinogenesis.
- cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis.
- Rosai-Dorfman disease presenting in the gastrointestinal tract.
- Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T-cells to Be Suppressed In Vivo.
- Association between cellular response (IL-4) to RESA/Pf155 and protection from clinical malaria among Papua New Guinean children living in a malaria endemic area.
- [Fundus spectrometry in age-related maculopathy].
- Cellular immunity to merozoite surface protein 2 (FC27 and 3D7) in Papua New Guinean children. Temporal variation and relation to clinical and parasitological status.
- Conditional binding to and cell cycle-regulated inhibition of cyclin-dependent kinase complexes by p27Kip1.
- Chimeric granulocyte/macrophage colony-stimulating factor/transforming growth factor-beta (TGF-beta) receptors define a model system for investigating the role of homo...
- Pneumocystis carinii contains a functional cell-division-cycle Cdc2 homologue.
- Interactions of parasite and host epithelial cell cycle regulation during Pneumocystis carinii pneumonia.
- Pneumocystis carinii modulates cyclin-dependant kinase activity in a lung epithelial cell line.
- Distinct endocytic responses of heteromeric and homomeric transforming growth factor beta receptors.
- Differential requirement for type I and type II transforming growth factor beta receptor kinase activity in ligand-mediated receptor endocytosis.
- Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.
- Differential regulation of p34cdc2 and p33cdk2 by transforming growth factor-beta 1 in murine mammary epithelial cells.
- Dual-phase computed tomographic angiography of focal nodular hyperplasia: defining predictable postcontrast attenuation levels relative to aorta and inferior vena cava.
- Pneumocystis carinii inhibits cyclin-dependent kinase activity in lung epithelial cells.
- Synchronous colorectal adenocarcinoma and gastrointestinal stromal tumor (GIST).
- Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.
- LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems.
- Management of large hepatocellular carcinoma in adult patients with Alagille syndrome: a case report and review of literature.
- Johns Hopkins course: 8th annual Current Topics in Gastrointestinal and Liver Pathology.
- Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3.
- Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion.
- Genomic and immunophenotypical differences between hepatocellular carcinoma with and without cirrhosis.
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of Chicago -
Mayo Medical School
Hospital
-
Johns Hopkins Bayview Medical Center -
Johns Hopkins Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1841254737 |
| Last Name Of The Provider | ANDERS |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Michael J. Borowitz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin A. Bishop, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Hicken, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nahid M. Nanaji, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Juan Troncoso, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelly M. Brenan Rothschild, MD |
|
|
Dr. William M. Baldwin III, MD |
|
|
Dr. Jennifer A. Collins, DO |
|
|
Dr. Max K. Fischer, MD |
|
|
Dr. Maria Lee, MD |
|
|
Dr. Doreen N. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tehmina Z. Ali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emanuela F. Veras, MD |